| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8227(99)00113-8 |
| P698 | PubMed publication ID | 10624783 |
| P2093 | author name string | T M Gross | |
| B W Bode | |||
| J J Mastrototaro | |||
| K R Thornton | |||
| P2860 | cites work | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| The cost to health plans of poor glycemic control | Q40875406 | ||
| The Hawthorne effect: A reconsideration of the methodological artifact | Q56287142 | ||
| P433 | issue | 3 | |
| P921 | main subject | glucose monitoring | Q95987978 |
| glycated hemoglobin | Q311213 | ||
| P304 | page(s) | 183-190 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Diabetes Research and Clinical Practice | Q15750054 |
| P1476 | title | Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study | |
| P478 | volume | 46 |
| Q35680365 | A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data. |
| Q44347734 | A microscopic, continuous, optical monitor for interstitial electrolytes and glucose |
| Q43808984 | A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects |
| Q46115371 | A pilot study to evaluate a novel subcutaneous continuous glucose monitoring system in healthy Beagle dogs |
| Q36293404 | A review of continuous glucose monitoring technology |
| Q37404189 | A review of current evidence with continuous glucose monitoring in patients with diabetes |
| Q44530801 | Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemia |
| Q33674517 | Accuracy of a new real-time continuous glucose monitoring algorithm |
| Q45245389 | Accuracy of continuous nocturnal glucose screening after 48 and 72 hours in type 2 diabetes patients on combined oral and insulin therapy |
| Q37404459 | Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements |
| Q44440835 | Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. |
| Q62636728 | Adaptive control strategy for regulation of blood glucose levels in patients with type 1 diabetes |
| Q36007863 | Advances in diabetes for the millennium: insulin treatment and glucose monitoring. |
| Q44874898 | Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system |
| Q30807333 | Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms |
| Q64969071 | Assessing glycemia in type 1 diabetic patients using a microdialysis system for continuous glucose monitoring. |
| Q36732401 | Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements |
| Q51139622 | Biocompatibility of electrochemical glucose sensors implanted in the subcutis of pigs. |
| Q34316031 | Can interstitial glucose assessment replace blood glucose measurements? |
| Q43253506 | Case Study: using a continuous glucose monitoring system in a patient with diabetes and beta-thalassemia hemoglobinopathy |
| Q51476588 | Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. |
| Q40603108 | Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs |
| Q74255119 | Clinical utility of the continuous glucose monitoring system |
| Q50932408 | Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetes. |
| Q44386533 | Closed-loop glucose control in critically ill patients using continuous glucose monitoring system (CGMS) in real time |
| Q36695527 | Comparison of Glycemic Excursion in Patients with New Onset Type 2 Diabetes Mellitus before and after Treatment with Repaglinide. |
| Q41528253 | Continuous Glucose Monitor Use and Accuracy in Hospitalized Patients |
| Q33308776 | Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis. |
| Q36335124 | Continuous Glucose Monitoring Systems: A Review |
| Q37080094 | Continuous glucose monitoring and diabetes health outcomes: a critical appraisal |
| Q35134220 | Continuous glucose monitoring during pregnancy complicated by gestational diabetes mellitus |
| Q43934863 | Continuous glucose monitoring in children with glycogen storage disease type I. |
| Q44813945 | Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy |
| Q45155175 | Continuous glucose monitoring in conditions other than diabetes |
| Q34129614 | Continuous glucose monitoring in non-insulin-using individuals with type 2 diabetes: acceptability, feasibility, and teaching opportunities |
| Q38092268 | Continuous glucose monitoring in small animals |
| Q37332857 | Continuous glucose monitoring in type 2 diabetes |
| Q36519725 | Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial |
| Q37308466 | Continuous glucose monitoring: a review of biochemical perspectives and clinical use in type 1 diabetes |
| Q45996431 | Continuous glucose monitoring: an overview of its development. |
| Q36108412 | Continuous glucose monitoring: roadmap for 21st century diabetes therapy |
| Q44911251 | Continuous glucose monitoring: which benefits? |
| Q36968121 | Continuous glucose monitors: the long-awaited watch dogs? |
| Q81234672 | Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes |
| Q44427577 | Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study |
| Q31832735 | Continuous subcutaneous glucose monitoring in children with type 1 diabetes |
| Q46667179 | Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes |
| Q30455250 | Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons |
| Q61799606 | Decreased complexity of glucose dynamics in diabetes in rhesus monkeys |
| Q37689912 | Delays in minimally invasive continuous glucose monitoring devices: a review of current technology |
| Q57412676 | Diabetes Disease Management: Past, Present, and Future |
| Q34580945 | Diabetes management in the new millennium using insulin pump therapy |
| Q43972613 | Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? |
| Q36340521 | Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study |
| Q46882462 | Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature |
| Q41104232 | Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease |
| Q46014931 | Efficacy and reliability of the continuous glucose monitoring system. |
| Q50792500 | Evaluation of a continuous glucose monitoring system compared with an in-house standard laboratory assay and a handheld point-of-care glucometer in critically ill neonatal foals. |
| Q46515432 | Evaluation of a continuous glucose monitoring system in cats with diabetes mellitus |
| Q44634754 | Evaluation of a continuous glucose monitoring system in diabetic dogs |
| Q44786462 | Evaluation of a new insulinotropic agent by using an innovative technology: efficacy and safety of nateglinide determined by continuous glucose monitoring |
| Q43225353 | Evaluation of a novel real-time continuous glucose-monitoring system for use in cats |
| Q39300979 | Evaluation of accuracy of ambulatory glucose profile in an outpatient setting in children with type 1 diabetes |
| Q44114826 | Evaluation of conventional blood glucose monitoring as an indicator of integrated glucose values using a continuous subcutaneous sensor |
| Q41973961 | Evaluation of glucose response to 3 types of insulin using a continuous glucose monitoring system in healthy alpacas. |
| Q45199907 | Evaluation of pyranine derivatives in boronic acid based saccharide sensing: significance of charge interaction between dye and quencher in solution and hydrogel |
| Q35583877 | Evolving approaches to intensive insulin therapy in type 1 diabetes: multiple daily injections, insulin pumps and new methods of monitoring |
| Q60290519 | Ex Vivo Continuous Glucose Monitoring With Microdialysis Technique: The Example of GlucoDay |
| Q46685594 | Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus |
| Q80182537 | Function and accuracy of glucose sensors beyond their stated expiry date |
| Q35954484 | Glucose control in diabetes |
| Q46652856 | Glucose metabolism disorder in obese children assessed by continuous glucose monitoring system |
| Q46892813 | Glycaemic control with modified intensive insulin injections (MII) using insulin pens and premixed insulin in children with type-1 diabetes: a randomized controlled trial |
| Q49612552 | Glycemic Variability and Vascular Complications in Patients with Type 2 Diabetes Mellitus |
| Q40385870 | Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values |
| Q80544945 | Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin |
| Q37172341 | Guideline for management of postmeal glucose |
| Q46800167 | High day-to-day glucose variability: a frequent phenomenon in children and adolescents with type 1 diabetes attending summer camp |
| Q37080087 | How to assess and compare the accuracy of continuous glucose monitors? |
| Q28728923 | Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men |
| Q42687413 | Implantable glucose sensors for diabetes monitoring |
| Q91612191 | Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts |
| Q37404609 | Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: prospective results from a community and academic practice patient registry |
| Q44715650 | Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). |
| Q42176960 | In silico evaluation of a control system and algorithm for automated insulin infusion in the ICU setting |
| Q43091486 | Individualizing care for the many: the evolving role of professional continuous glucose monitoring systems in clinical practice |
| Q46513435 | Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes |
| Q36116370 | Insulin pump therapy in childhood diabetes mellitus: guidelines for use. |
| Q34663256 | Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes |
| Q26740630 | Interactions between kidney disease and diabetes: dangerous liaisons |
| Q89002574 | Interstitium versus Blood Equilibrium in Glucose Concentration and its Impact on Subcutaneous Continuous Glucose Monitoring Systems |
| Q84529099 | Intraindividual differences between two simultaneous glucose measurement systems in type 2 diabetic patients |
| Q36122322 | Is self-monitoring of blood glucose effective in improving glycaemic control in type 2 diabetes without insulin treatment: a meta-analysis of randomised controlled trials |
| Q60447638 | La monitorización continua de glucosa a tiempo real y los servicios nacionales de salud. ¿Hay suficiente evidencia científica para justificar su financiación pública? |
| Q43778825 | Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes |
| Q51709142 | Local release of masitinib alters in vivo implantable continuous glucose sensor performance. |
| Q34580967 | Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice |
| Q36293413 | Making sense of glucose monitoring technologies: from SMBG to CGM. |
| Q34722011 | Measuring and managing hyperglycemia in pregnancy: from glycosuria to continuous blood glucose monitoring |
| Q31042619 | Micro-miniature autonomous optical sensor array for monitoring ions and metabolites 1: design, fabrication, and data analysis |
| Q59036413 | Mobile Telemedicine for Diabetes Care |
| Q42455167 | Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis |
| Q91636020 | Monitoring of Pediatric Type 1 Diabetes |
| Q35224968 | New-generation diabetes management: glucose sensor-augmented insulin pump therapy |
| Q46862142 | Nocturnal differences in subcutaneous tissue glucose between forearm and abdominal sites during continuous glucose monitoring in normal subjects. |
| Q51475008 | Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations. |
| Q35954489 | Nocturnal hypoglycaemia in type 1 diabetes--consequences and assessment. |
| Q34655720 | Nocturnal hypoglycaemias in type 1 diabetic patients: what can we learn with continuous glucose monitoring? |
| Q46981074 | Non-invasive glucose monitoring in patients with diabetes: a novel system based on impedance spectroscopy |
| Q45955162 | Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. |
| Q44665347 | Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects |
| Q46564377 | Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. |
| Q44228145 | Performance of a continuous glucose monitoring system during controlled hypoglycaemia in healthy volunteers |
| Q44548210 | Poor glucose control in women with type 1 diabetes mellitus and 'safe' hemoglobin A1c values in the first trimester of pregnancy |
| Q37761915 | Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections. |
| Q44195278 | Prevention of hypoglycemia using risk assessment with a continuous glucose monitoring system |
| Q43685455 | Re: Diabetes technology & therapeutics, 2000; 2:49-56. |
| Q45916671 | Real-time adaptive models for the personalized prediction of glycemic profile in type 1 diabetes patients. |
| Q42658293 | Real-time glucose sensing using transdermal fluid under continuous vacuum pressure in children with type 1 diabetes |
| Q91647229 | Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes |
| Q34434731 | Recent advances in treatment of youth with Type 1 diabetes: better care through technology |
| Q44157871 | Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study |
| Q44231057 | Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring |
| Q34585108 | Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor |
| Q44043331 | Reproducibility of glucose measurements using the glucose sensor. |
| Q46034672 | Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus. |
| Q33905394 | Retrospective study of owners' perception on home monitoring of blood glucose in diabetic dogs and cats |
| Q46835362 | Role of the continuous glucose monitoring system in pediatric patients |
| Q43697344 | Searching for glycemic control in pediatric type 1 diabetes: A long way to go. |
| Q37575119 | Self glucose monitoring and physical exercise in diabetes |
| Q36078742 | Self-monitoring of blood glucose in children and teens with diabetes |
| Q37614534 | Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis |
| Q24203867 | Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin |
| Q24244111 | Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin |
| Q24246526 | Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin |
| Q36141356 | Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review |
| Q34221677 | Sensors for glucose monitoring: technical and clinical aspects |
| Q44114796 | Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes |
| Q43720063 | Subcutaneous continuous glucose monitoring: feasibility of a new microdialysis-based glucose sensor system |
| Q34143382 | Tech.Sight. Biochemistry. Biosensors--sense and sensitivity. |
| Q37575099 | Technology and the issue of cost/benefit in diabetes. |
| Q44120124 | The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk. |
| Q34491051 | The Correlation and Accuracy of Glucose Levels between Interstitial Fluid and Venous Plasma by Continuous Glucose Monitoring System |
| Q91125175 | The Impact of Short-Term Professional Continuous Glucose Monitoring on Glycemic Control Via Lifestyle Improvement |
| Q44381371 | The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control |
| Q34317300 | The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system |
| Q37140190 | The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review |
| Q39631923 | The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients |
| Q35867551 | The public health impact of the MiniMed Continuous Glucose Monitoring System (CGMS)-an assessment of the literature |
| Q37138797 | The relationship between HbA1c values and the occurrence of hypoglycemia as assessed by continuous glucose monitoring in patients with type 1 diabetes |
| Q33337497 | The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada |
| Q80432304 | The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy |
| Q34543845 | Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1 diabetes mellitus |
| Q34583229 | Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study |
| Q45184502 | Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial |
| Q62495821 | Wearables in Medicine |
| Q34228818 | What's ahead in glucose monitoring? New techniques hold promise for improved ease and accuracy |
Search more.